DNA Damage Response in Neurodegeneration

DNA Damage Response in Neurodegeneration

Introduction

DNA damage response in neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

The DNA damage response (DDR) is a critical cellular surveillance mechanism that maintains genomic integrity by detecting DNA lesions, activating repair pathways, and orchestrating cell cycle checkpoints. Key DNA repair proteins implicated in neurodegeneration include PRKDC (DNA-PKcs), XRCC6 (Ku70), XRCC5 (Ku80), and PARP1. In neurodegenerative diseases, progressive accumulation of DNA damage contributes to neuronal dysfunction and cell death. This pathway page explores the molecular mechanisms by which DNA damage accumulates in neurons, how impaired DNA repair promotes neurodegeneration, and therapeutic strategies targeting DDR components.

DNA Damage Types in the Brain

Neurons are particularly vulnerable to DNA damage due to their high metabolic activity, post-mitotic state, and exposure to reactive oxygen species. The major types of DNA damage affecting neurons include:

DNA Damage Response in Neurodegeneration

Introduction

DNA damage response in neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

The DNA damage response (DDR) is a critical cellular surveillance mechanism that maintains genomic integrity by detecting DNA lesions, activating repair pathways, and orchestrating cell cycle checkpoints. Key DNA repair proteins implicated in neurodegeneration include PRKDC (DNA-PKcs), XRCC6 (Ku70), XRCC5 (Ku80), and PARP1. In neurodegenerative diseases, progressive accumulation of DNA damage contributes to neuronal dysfunction and cell death. This pathway page explores the molecular mechanisms by which DNA damage accumulates in neurons, how impaired DNA repair promotes neurodegeneration, and therapeutic strategies targeting DDR components.

DNA Damage Types in the Brain

Neurons are particularly vulnerable to DNA damage due to their high metabolic activity, post-mitotic state, and exposure to reactive oxygen species. The major types of DNA damage affecting neurons include:

| Damage Type | Source | Repair Pathway | Neurodegenerative Relevance |
|-------------|--------|----------------|----------------------------|
| Oxidative lesions (8-oxoG) | ROS from metabolism | Base excision repair (BER) | AD, PD, ALS |
| Single-strand breaks | Oxidative stress, repair intermediates | BER, SSB repair | AD, PD |
| Double-strand breaks | Radiation, oxidative stress, replication stress | NHEJ, HR | ALS, Ataxias |
| DNA base alkylation | Endogenous metabolites | Direct reversal, BER | AD, Aging |
| Interstrand crosslinks | Oxidative stress, environmental | Fanconi anemia pathway | ALS, Huntington's |
| Telomere shortening | Replicative aging | Telomerase, alternative lengthening | Aging, AD |

Molecular Cascade

Key DNA Damage Sensors

PARP1/PARP2 (Poly ADP-ribose polymerases)

• Detect single-strand breaks and base damage
• Catalyze poly(ADP-ribosyl)ation of target proteins
• Recruit XRCC1/Ligase III for repair
• Overactivation leads to NAD+ depletion and cell death
• PARP inhibitors show promise in PD and ALS models

• Primary sensor for double-strand breaks
• Phosphorylates p53, CHK2, H2AX
• Activates cell cycle checkpoints
• ATM deficiency causes ataxia-telangiectasia with neurodegeneration

• Responds to replication stress and single-strand breaks
• Activates CHK1 and S-phase checkpoint
• Important for neuronal survival under stress

DNA Repair Pathways

| Pathway | Substrates | Key Proteins | Neuronal Role |
|---------|------------|--------------|---------------|
| Base excision repair (BER) | Oxidative damage, alkylation | OGG1, NTH1, PARP1, Pol β, Lig III | Critical for removing 8-oxoG and ROS damage |
| Nucleotide excision repair (NER) | UV damage, bulky adducts | XPA-G, TFIIH, ERCC1 | Repair of transcription-blocking lesions |
| Mismatch repair (MMR) | Replication errors | MSH2/6, MLH1, PMS2 | Implicated in triplet repeat expansion |
| Non-homologous end joining (NHEJ) | DSB | Ku70/80, DNA-PKcs, Ligase IV | Primary DSB repair in neurons |
| Homologous recombination (HR) | DSB in S/G2 | RAD51, BRCA1/2, PALB2 | Limited in post-mitotic neurons |
| Direct reversal | Alkylation | MGMT, ALKBH2/3 | Quick repair of specific damage |

Disease-Specific Mechanisms

Alzheimer's Disease

In AD, DNA damage accumulates through multiple mechanisms:

• Amyloid-β induced damage: Aβ oligomers increase ROS production, causing oxidative DNA damage
• Tau pathology: Hyperphosphorylated tau impairs DNA repair by sequestering DNA-PK
• Mitochondrial dysfunction: mtDNA mutations accumulate in AD neurons
• Impaired BER: Reduced OGG1 activity leads to 8-oxoG accumulation
• Telomere shortening: Accelerated telomere attrition in AD patients

• Elevated 8-oxoG levels in AD brain (3-5 fold increase)
• Reduced PARP1 activity in AD neurons (paradoxical - can indicate exhaustion)
• Increased p53 and p21 expression in vulnerable neurons
• DNA-PKcs activity reduced in AD hippocampus

Parkinson's Disease

DNA damage in PD is linked to:

• Dopamine oxidation: Auto-oxidation of dopamine generates reactive oxygen species
• Mitochondrial Complex I deficiency: Leads to ROS production and mtDNA damage
• α-Synuclein toxicity: Can directly interact with DNA and impair repair
• LRRK2 mutations: Affect DNA damage response signaling
• GBA1 deficiency: Leads to increased oxidative stress and DNA damage

• Increased γH2AX foci in PD substantia nigra neurons
• Reduced OGG1 and PARP1 activity
• Accumulation of mtDNA deletions in dopaminergic neurons
• Enhanced sensitivity to genotoxic stress in LRRK2 mutant models

Amyotrophic Lateral Sclerosis

DNA damage accumulation in ALS:

• C9orf72 expansions: RNA foci and dipeptide repeats cause R-loop formation
• SOD1 mutations: Produce ROS, causing oxidative DNA damage
• TDP-43 pathology: Impairs transcription and DNA repair gene expression
• FUS mutations: Disrupt DNA damage response
• Chronic DDR activation: Leads to p53-mediated apoptosis

• Elevated DNA damage markers in ALS motor neurons
• Reduced DNA repair capacity (BER, NER)
• TDP-43 mislocalization impairs DDR signaling
• C9orf72 patient-derived neurons show increased DNA damage

Huntington's Disease

DNA damage in HD:

• Mutant huntingtin: Directly binds DNA and impairs repair complexes
• Transcriptional dysfunction: Leads to DNA replication stress
• Mitochondrial dysfunction: Causes oxidative DNA damage
• Triplet repeat instability: Expands in neurons over time

Therapeutic Strategies

DNA Repair Enhancement

| Strategy | Target | Compound/Approach | Status |
|----------|--------|-------------------|--------|
| PARP inhibition | PARP1/2 | Olaparib, rucaparib | Preclinical AD/PD |
| p53 modulation | p53 | Pifithrin-α | Preclinical |
| BER enhancement | Pol β, Lig III | Gene therapy approaches | Research |
| NER enhancement | XPA, TFIIH | Small molecule activators | Research |
| Telomerase activation | Telomerase | TA-65, gene therapy | Aging research |

Antioxidant Approaches

• Mitochondrial antioxidants: CoQ10, MitoQ target mtDNA damage
• NAC and glutathione: Boost cellular antioxidant capacity
• Metal chelation: Deferoxamine reduces iron-induced damage

Gene Therapy

• OGG1 delivery: Adenoviral OGG1 to enhance 8-oxoG repair
• PARP1 modulation: AAV-delivered PARP inhibitors
• Ataxia-telangiectasia: ATM gene therapy in development

Biomarkers

| Biomarker | Detection | Disease | Utility |
|-----------|-----------|---------|---------|
| 8-oxoG in CSF | ELISA, mass spec | AD, PD | Diagnostic |
| γH2AX foci | Immunohistochemistry | ALS, PD | Research |
| Tail moment (Comet assay) | Single cell gel electrophoresis | All | Research |
| p53 phosphorylation | Western blot | AD, PD | Prognostic |
| ATM activation | Immunohistochemistry | Ataxias | Diagnostic |

Cross-Pathway Interactions

The DNA damage response intersects with multiple neurodegenerative pathways:

• Mitochondrial dysfunction: Bidirectional - mtDNA damage causes dysfunction, and mitochondrial dysfunction produces ROS that damage nuclear DNA
• Oxidative stress pathway: Primary source of endogenous DNA damage
• Neuroinflammation: Chronic inflammation produces ROS and RNS that damage DNA
• Cellular senescence: Persistent DDR contributes to senescence-associated secretory phenotype (SASP)
• Protein quality control: DNA damage can trigger the unfolded protein response

See Also

• [Oxidative Stress in Neurodegeneration](/mechanisms/oxidative-stress-neurodegeneration)
• [Synaptic Dysfunction in Neurodegeneration](/mechanisms/synaptic-dysfunction-neurodegeneration)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)

References

Confidence Assessment

🟡 Medium Confidence

| Dimension | Score |
|-----------|-------|
| Supporting Studies | 5 verified references |
| Contradicting Evidence | 0% |
| Mechanistic Completeness | 70% |

Overall Confidence: 65%

Pathway Diagram

The following diagram shows the key molecular relationships involving DNA Damage Response in Neurodegeneration discovered through SciDEX knowledge graph analysis: